Literature DB >> 18638569

S1P and eNOS regulation.

Junsuke Igarashi1, Thomas Michel.   

Abstract

In the mammalian cardiovascular system, nitric oxide (NO), a small diffusible gaseous signal mediator, plays pivotal roles in the maintenance of vascular homeostasis. The endothelial isoform of nitric oxide synthase (eNOS) is activated by diverse agonist-modulated cell surface receptors, and eNOS-derived NO is a key determinant of blood pressure, platelet activation, angiogenesis and other fundamental responses in the vascular wall. Sphingosine 1-phosphate (S1P) has recently been identified as an important activator of eNOS. This review summarizes the roles of sphingosine 1-phosphate and S1P receptors in eNOS activation, and analyzes the eNOS regulatory processes evoked by S1P. The implications of S1P activation of eNOS in cardiovascular (patho)physiology will be also discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18638569     DOI: 10.1016/j.bbalip.2008.06.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

Review 1.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

2.  Junctional protein regulation by sphingosine kinase 2 contributes to blood-brain barrier protection in hypoxic preconditioning-induced cerebral ischemic tolerance.

Authors:  Bradley K Wacker; Angela B Freie; Jennifer L Perfater; Jeffrey M Gidday
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-08       Impact factor: 6.200

3.  Serum vascular endothelial growth factor receptor-2 and adropin levels in age-related macular degeneration.

Authors:  Nurgül Örnek; Kemal Örnek; Süleyman Aydin; Musa Yilmaz; Yaşar Ölmez
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

4.  L-cysteine/cystathionine-β-synthase-induced relaxation in mouse aorta involves a L-serine/sphingosine-1-phosphate/NO pathway.

Authors:  Emma Mitidieri; Danila Gurgone; Elisabetta Caiazzo; Teresa Tramontano; Carla Cicala; Raffaella Sorrentino; Roberta d'Emmanuele di Villa Bianca
Journal:  Br J Pharmacol       Date:  2019-04-22       Impact factor: 8.739

5.  An engineered S1P chaperone attenuates hypertension and ischemic injury.

Authors:  Steven L Swendeman; Yuquan Xiong; Anna Cantalupo; Hui Yuan; Nathalie Burg; Yu Hisano; Andreane Cartier; Catherine H Liu; Eric Engelbrecht; Victoria Blaho; Yi Zhang; Keisuke Yanagida; Sylvain Galvani; Hideru Obinata; Jane E Salmon; Teresa Sanchez; Annarita Di Lorenzo; Timothy Hla
Journal:  Sci Signal       Date:  2017-08-15       Impact factor: 8.192

Review 6.  Unraveling the complexities of the HDL lipidome.

Authors:  Anatol Kontush; Marie Lhomme; M John Chapman
Journal:  J Lipid Res       Date:  2013-03-30       Impact factor: 5.922

Review 7.  Molecular signature of nitric oxide on major cancer hallmarks of colorectal carcinoma.

Authors:  Paramita Mandal
Journal:  Inflammopharmacology       Date:  2017-12-30       Impact factor: 4.473

8.  FTY720 prevents progression of renal fibrosis by inhibiting renal microvasculature endothelial dysfunction in a rat model of chronic kidney disease.

Authors:  Haifeng Ni; Junfeng Chen; Mingming Pan; Minghui Zhang; Jiandong Zhang; Pingsheng Chen; Bicheng Liu
Journal:  J Mol Histol       Date:  2013-08-02       Impact factor: 2.611

Review 9.  Sphingosine-1-phosphate receptor signalling in the heart.

Authors:  Christopher K Means; Joan Heller Brown
Journal:  Cardiovasc Res       Date:  2009-03-12       Impact factor: 10.787

10.  Nogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure.

Authors:  Anna Cantalupo; Yi Zhang; Milankumar Kothiya; Sylvain Galvani; Hideru Obinata; Mariarosaria Bucci; Frank J Giordano; Xian-Cheng Jiang; Timothy Hla; Annarita Di Lorenzo
Journal:  Nat Med       Date:  2015-08-24       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.